Migraine Newswire

Migraine Newswire

Comprehensive Real-Time News Feed for Migraine.

Results 1 - 20 of 357 in Migraine

  1. People's Pharmacy: Will ice stop a killer headache?Read the original story w/Photo

    2 hrs ago | Athens Banner-Herald

    ... are available over the counter, and so are herbs such as butterbur and feverfew. A doctor could prescribe a migraine medicine such as sumatriptan, which often reverses severe headaches promptly. If he is suffering from cluster headaches, breathing ...

    Comment?

  2. Better Buy: Amgen Inc. vs. PfizerRead the original story w/Photo

    11 hrs ago | The Motley Fool

    ... several of its existing drugs. Amgen's pipeline includes two new candidates in late-stage testing -- experimental migraine drug erenumab and heart failure drug omecamtiv mecarbil. Amgen is in excellent position to bolster its pipeline through ...

    Comment?

  3. it's All in Your Head:Read the original story

    Friday Apr 21 | BrothersJudd Blog

    ... their effectiveness when the patient did not know that he or she had just been given a painkiller. A study of the migraine drug rizatriptan found no statistical difference between a placebo labeled rizatriptan and actual rizatriptan labeled placebo. ...

    Comment?

  4. These five strains of medicinal marijuana ease migrainesRead the original story w/Photo

    Tuesday Apr 18 | NewsTarget.com

    ... energetic euphoria that helps the body attain full relaxation. White widow is known to manage even severe forms of migraine. Cannatonic - This strain is known for having low levels of tetrahydrocannabinol , a molecule associated with the ...

    Comment?

  5. FDA Approves Vagus Nerve Stimulator to Treat Cluster HeadachesRead the original story w/Photo

    Tuesday Apr 18 | MSNBC

    ... sudden headaches in a single day for days on end. There aren't many specific treatments but they include the migraine drug sumatriptan, delivered via auto-injector, and inhaled oxygen. Both approaches are limited - it's not safe to use the injection ...

    Comment?

  6. Supernus: Turning Headaches Into ADHD TreatmentsRead the original story w/Photo

    Tuesday Apr 18 | Seeking Alpha

    Supernus announced final FDA approval for Trokendi XR for treatment of migraine prophylaxis in adults and adolescents over 12 years of age. The company is developing two ADHD candidates, SPN-810 and SPN-812, with predicted annual markets exceeding 3 billion dollars per year.

    Comment?

  7. Pain Therapeutics Report (2017-2026) - Assessment of Pain & Analgesics - Research and MarketsRead the original story

    Monday Apr 17 | Customer Interaction Solutions

    ... Various pain syndromes require different approaches in management, for example, the main category of drugs for migraine are triptans such as sumatriptan. Advances in molecular and biological techniques are markedly advancing our understanding of ...

    Comment?

  8. Sarah Ivens: Five migraine cures that actually work... from Epsom salts to peppermint shampooRead the original story w/Photo

    Sunday Apr 16 | The New Zealand Herald

    ... their reproductive age. As a 41-year-old with two young children (aged five and three), I am a classic menstrual migraine candidate. Recently though, there was some hopeful news for women like me and other migraine sufferers - including Serena ...

    Comment?

  9. Caffeine highRead the original story w/Photo

    Saturday Apr 15 | Manila Bulletin

    ... chocolate has more at 30mg. Some pain-killers (analgesics) contain 60-130mg of caffeine. Ergotamine with caffeine (migraine treatment) comes in a rectal suppository but this is not the way I want to take my coffee. Now if a heavy smoker is someone ...

    Comment?

  10. 3 Things In Biotech You Should Learn Today: April 15, 2017Read the original story w/Photo

    Saturday Apr 15 | Seeking Alpha

    ... with American regulators later this year. Looking forward: An approval of an alternate form of an already-approved migraine drug (Merck's rizatriptan) may not seem incredibly sexy, but it is certainly a start for RDHL, which is looking for its first ...

    Comment?

  11. RedHill Biopharma And IntelGenx Corp. Announce Marketing Approval Of...Read the original story

    Wednesday Apr 12 | BioSpace

    ... in each country. RIZAPORTA offers an innovative and potentially advantageous therapeutic alternative for many migraine patients, primarily patients who suffer from dysphagia or migraine-related nausea, due to its convenient dosing, facile intake due ...

    Comment?

  12. Say no to migraine medication and yes to natural careRead the original story w/Photo

    Thursday Apr 13 | The Philipine Reporter

    If you've ever experienced a migraine headache, you know how debilitating it can be. According to the Mayo Clinic, "a migraine headache can cause intense throbbing or pulsing in one area of the head and is commonly accompanied by nausea, vomiting, and extreme sensitivity to light and sound.

    Comment?

  13. RedHill Biopharma and IntelGenx Announce Marketing Approval of RIZAPORT for Migraines in LuxembourgRead the original story

    Thursday Apr 13 | World News Report

    ... in each country. RIZAPORT® offers an innovative and potentially advantageous therapeutic alternative for many migraine patients, primarily patients who suffer from dysphagia or migraine-related nausea, due to its convenient dosing, facile ...

    Comment?

  14. IntelGenx and RedHill Biopharma Announce Marketing Approval of...Read the original story

    Thursday Apr 13 | World News Report

    ... in each country. RIZAPORTA offers an innovative and potentially advantageous therapeutic alternative for many migraine patients, primarily patients who suffer from dysphagia or migraine-related nausea, due to its convenient dosing, facile intake due ...

    Comment?

  15. First photoactive drug for pain treatmentRead the original story w/Photo

    Wednesday Apr 12 | PhysOrg Weblog

    ... thus far," says Ciruela. "Actually, the raseglurant was examined in clinical trials as an analgesic to treat migraine, but it was ruled out due its hepatoxicity. This new optopharmacology of the raseglurant can stop adverse effects in the liver and ...

    Comment?

  16. First 'photo-drug' for pain can be activated anytime with lightRead the original story

    Tuesday Apr 11 | Newkerala.com

    ... said Ciruela. Ciruela added, "Actually, the raseglurant was examined in clinical trials as an analgesic to treat migraine but it was ruled out due its hepatoxicity. This new optopharmacology of the raseglurant can stop adverse effects in the liver ...

    Comment?

  17. First photoactive drug for pain treatmentsRead the original story w/Photo

    Monday Apr 10 | EurekAlert!

    ... says Ciruela. "Actually, -adds Ciruela-, the raseglurant was examined in clinical trials as an analgesic to treat migraine but it was ruled out due its hepatoxicity. This new optopharmacology of the raseglurant can stop adverse effects in the liver ...

    Comment?

  18. Induction of Migraine-Like Photophobic Behavior in Mice by Both...Read the original story

    Monday Apr 10 | CiteULike

    ... and drag-and-drop it into the document. The neuropeptide calcitonin gene-related peptide (CGRP) is a key player in migraine. Although migraine can be treated using CGRP antagonists that act peripherally, the relevant sites of CGRP action remain ...

    Comment?

  19. Dopamine Levels Drop Significantly During Migraine AttacksRead the original story w/Photo

    Monday Apr 10 | PsychCentral

    Scientists have discovered that the neurotransmitter dopamine drops significantly during a migraine headache and then fluctuates at various times during the attack, according to a new PET scan study at the University of Michigan . The findings offer new insights into how dopamine-based migraine treatments work and also give scientists a better understanding of patients' behavior during an attack.

    Comment?

  20. Depression of home cage wheel running: a reliable and clinically...Read the original story

    Saturday Apr 8 | CiteULike

    To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. The development of new anti-migraine treatments is limited by the difficulty inassessing migraine pain in laboratory animals.

    Comment?